REFERENCES
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, et al. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA-Cancer J Clin 2018;68:394-424.
2. Edgren G, Adami HO, Weiderpass E, Nyrén O. A global assessment of the oesophageal adenocarcinoma epidemic. Gut 2013;62:1406-14.
3. Bollschweiler E, Wolfgarten E, Gutschow C, Hölscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001;92:549-55.
4. Hashimoto T, Kurokawa Y, Mori M, Doki Y. Surgical Treatment of Gastroesophageal Junction Cancer. J Gastric Cancer 2018;18:209-17.
5. Lewis I. The surgical treatment of carcinoma of the esophagus; with special reference to a new operation for growths of the middle third. Br J Surg 1946;34:18-31.
6. Huang L, Onaitis M. Minimally invasive and robotic Ivor Lewis esophagectomy. J Thorac Dis 2014;6:S314-21.
7. Palanivelu C, Prakash A, Senthilkumar R, Senthilnathan P, Parthasarathi R, et al. Minimally invasive esophagectomy: thoracoscopic mobilization of the esophagus and mediastinal lymphadenectomy in prone position-experience of 130 patients. J Am Coll Surg 2006;203:7-16.
8. Palanivelu C, Prakash A, Parthasarathi R, Senthilkumar R, Senthilnathan PR, et al. Laparoscopic esophagogastrectomy without thoracic or cervical access for adenocarcinoma of the gastroesophageal junction: an Indian experience from a tertiary center. Surg Endosc 2007;21:16-20.
9. Watson DI, Davies N, Jamieson GG. Totally endoscopic Ivor Lewis esophagectomy. Surg Endosc 1999;13:293-7.
10. Bizekis C, Kent MS, Luketich JD, Buenaventura PO, Landreneau RJ, et al. Initial experience with minimally invasive Ivor Lewis esophagectomy. Ann Thorac Surg 2006;82:402-6.
11. Baranov NS, van Workum F, van der Maas J, Kouwenhoven E, van Det M, et al. The Influence of Age on Complications and Overall Survival After Ivor Lewis Totally Minimally Invasive Esophagectomy. J Gastrointest Surg 2019;23:1293-300.
12. Deng J, Su Q, Ren Z, Wen J, Xue Z, et al. Comparison of short-term outcomes between minimally invasive McKeown and Ivor Lewis esophagectomy for esophageal or junctional cancer: a systematic review and meta-analysis. Onco Targets Ther 2018;11:6057-69.
13. Straatman J, van der WN, Cuesta MA, Daams F, Roig GS, et al. Minimally Invasive Versus Open Esophageal Resection: Three-year Follow-up of the Previously Reported Randomized Controlled Trial: the TIME Trial. Ann Surg 2017;266:232-6.
14. Tan L, Tang H. Oncological outcomes of the TIME trial in esophageal cancer: is it the era of minimally invasive esophagectomy? Ann Transl Med 2018;6:85.
15. van Workum F, Berkelmans GH, Klarenbeek BR, Nieuwenhuijzen GAP, Luyer MDP, et al. McKeown or Ivor Lewis totally minimally invasive esophagectomy for cancer of the esophagus and gastroesophageal junction: systematic review and meta-analysis. J Thorac Dis 2017;9:S826-33.
16. Yibulayin W, Abulizi S, Lv H, Sun W. Minimally invasive oesophagectomy versus open esophagectomy for resectable esophageal cancer: a meta-analysis. World J Surg Oncol 2016;14:304.
17. Rinieri P, Ouattara M, Brioude G, Loundou A, de Lesquen H, et al. Long-term outcome of open versus hybrid minimally invasive IvorLewis oesophagectomy: a propensity score matched study. Eur J Cardiothorac Surg 2017;51:223-9.
